David P Galloway
Overview
Explore the profile of David P Galloway including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
42
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Norris L, Giroux P, Jester T, Galloway D, Maclin J, Saaybi S, et al.
Am J Case Rep
. 2025 Feb;
26:e946099.
PMID: 40017015
BACKGROUND The incidence of Crohn's disease (CD) has increased worldwide. Although common presenting symptoms of CD in children include abdominal pain, diarrhea, and rectal bleeding, it can also present atypically...
2.
Modi B, Galloway D, Gura K, Nucci A, Plogsted S, Tucker A, et al.
JPEN J Parenter Enteral Nutr
. 2022 Apr;
46(6):1221-1222.
PMID: 35419805
No abstract available.
3.
Modi B, Galloway D, Gura K, Nucci A, Plogsted S, Tucker A, et al.
JPEN J Parenter Enteral Nutr
. 2021 Jul;
46(1):42-59.
PMID: 34287974
Pediatric intestinal failure (PIF) is a relatively rare disease entity that requires focused interdisciplinary care and specialized nutrition management. There has long been a lack of consensus in the definition...
4.
Effectiveness of a central line associated blood stream infection protocol in a pediatric population
Graham J, Shroyer M, Anderson S, Hutto C, Monroe K, Wilkinson L, et al.
Am J Surg
. 2021 May;
222(4):867-873.
PMID: 34053644
Background: Central line associated bloodstream infections are a common cause of bacteremia and sepsis in pediatric patients with intestinal failure, secondary to long-term CVC use. Methods: An IRB approved retrospective...
5.
Galloway D, Mathis M, Wilkinson L, Venick R, Wendel D, Cole C, et al.
JPEN J Parenter Enteral Nutr
. 2020 Sep;
45(1):50-56.
PMID: 32941671
Background: The coronavirus disease 2019 (COVID-19) pandemic has influenced how healthcare is being provided, particularly in patients whose diagnoses require multidisciplinary care, such as pediatric intestinal failure (IF). We sought...
6.
Enman M, Wilkinson L, Meloni K, Shroyer M, Jackson T, Aban I, et al.
JPEN J Parenter Enteral Nutr
. 2019 Dec;
44(7):1263-1270.
PMID: 31840829
Background: We sought to evaluate the relationship between determinants of intestinal failure (IF) and achieving enteral autonomy from parenteral nutrition (PN) in a large single-center cohort of children. Methods: This...
7.
Asouzu M, Shroyer M, Graham J, Wilkinson L, Galloway D, Martin C
J Pediatr Surg
. 2019 Apr;
54(10):2145-2148.
PMID: 30952453
Background/purpose: Although pediatric intestinal failure (IF) is now a survivable diagnosis, children are still at risk for complications. Loss of venous access persists as a leading indication for intestinal transplantation....
8.
Shen J, Hill B, Polhill S, Evans P, Galloway D, Johnson R, et al.
Am J Clin Pathol
. 2018 Oct;
151(3):306-315.
PMID: 30357374
Objectives: To investigate the utilization of CBC and CBC with differential (CBC w/diff) tests at University of Alabama at Birmingham Hospital, and to determine if a reduction in CBC w/diff...
9.
Galloway D, Wallihan D, Smith M, Abu-El-Haija M
Pancreas
. 2016 Jan;
45(2):e1-2.
PMID: 26752256
No abstract available.
10.
Galloway D, Troutt M, Kocoshis S, Gewirtz A, Ziegler T, Cole C
JPEN J Parenter Enteral Nutr
. 2014 Jun;
39(5):562-8.
PMID: 24898211
Background: Central line-associated bloodstream infections (CLABSIs) pose a significant challenge in the lives of patients with intestinal failure (IF). We hypothesized that plasma immunoglobulins against flagellin (FLiC) and lipopolysaccharide (LPS)...